Keyphrases
Ankylosing Spondylitis
42%
Axial Spondyloarthritis (AxSpA)
18%
Biologic DMARDs
18%
Biological Agents
23%
Biological Disease-modifying Antirheumatic Drugs (bDMARDs)
24%
Biological Treatment
20%
Collaborative Study
18%
Comorbidity
23%
Danish Population
28%
Denmark
24%
Disease Activity
18%
Gout
18%
Health Registries
18%
Inflammatory Arthritis
28%
Inhibitor Treatment
15%
Meta-analysis
29%
Monotherapy
26%
National Cohort Study
20%
National Register
19%
Obese Men
18%
OMERACT
20%
Pain Mechanisms
18%
PainDETECT
18%
Patient-reported Outcomes
19%
Population-based
28%
Prospective Cohort Study
22%
Prospective Observational Study
18%
Psoriatic Arthritis
100%
Randomized Trial
25%
Rheumatic Diseases
26%
Rheumatoid Arthritis
77%
Rheumatoid Arthritis Patients
25%
Southern Sweden
29%
Spondyloarthritis
19%
Sweden
22%
Systematic Meta-analysis
28%
TNF Inhibitors
29%
Tocilizumab
15%
Tumour Necrosis Factor Inhibitor (TNFi)
49%
Weight Loss
25%
Work Disability
18%
Medicine and Dentistry
Ankylosing Spondylitis
32%
Biological Product
27%
Cohort Analysis
66%
Cohort Effect
28%
Comorbidity
23%
Disease Activity
36%
Disease Modifying Antirheumatic Drug
16%
Disease-Modifying Antirheumatic Drug
20%
Gout
18%
Inflammatory Arthritis
85%
Observational Study
18%
Patient-Reported Outcome
32%
Psoriasis
17%
Psoriatic Arthritis
84%
Rheumatoid Arthritis
85%
Rheumatology
18%
Sex Difference
18%
Spondylarthritis
35%
Systematic Review
26%
TNF Inhibitor
49%
